Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088368819> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W3088368819 endingPage "S1007" @default.
- W3088368819 startingPage "S1007" @default.
- W3088368819 abstract "No specific safety data concerning systemic oncological treatments were available at time of COVID-19 outbreak in Belgium. In our hospital we decided to maintain adjuvant and early line treatments for metastatic disease in patients under 65 and without specific comorbidities and to apply a shared decision approach in other patients while following closely the safety of these treatments. Real time safety monitoring was proposed to all patients treated for solid tumours in our day-care unit starting March 1st, 2020. After signing informed consent patients were asked questions concerning protective measures at home, signs of SARS-CoV-2 infection and hospitalisation. Patients' charts were reviewed for outcome, including death, after suspected or proven SARS-CoV-2 infection. Minimum follow-up was 5 weeks after day care unit attendance. 387 patients were included in our registry between March 1st and March 31st, 2020. Median age was 64 years-old (range 27-90). Most patients suffered from lung (n=96), breast (n=93), gastrointestinal (n=87), gynaecological (n=38) or urological (n=33) cancers. 131 patients received (neo)adjuvant treatments, 256 patients were treated for metastatic disease. Patients received chemotherapy (n=170), immunotherapy (n=103), targeted therapy (n=68) or other combinations (n=46). Although Belgium had one of the highest infection rates in the world, safety data concerning risk of SARS-CoV-2 infection and outcomes were rather reassuring. A total of 11 patients had either suspected (n=5, 1.3%) or proven (n=6, 1.6%) SARS-CoV-2 infection. Only one 74 years old patient died of COVID-19, another 51 years old patient died of progressive disease but presented also suspicion of SARS-CoV-2 infection at the time of death. Analysis of our data for patients treated in March 2020 in the day-care unit are reassuring and suggest higher risk related to under-treatment compared to risk related to continuation of systemic therapy at time of COVID-19 outbreak. Patients' follow-up will be updated and additional analyses and data in particular for April 2020, when the infection rate was still extremely high in Belgium, will be presented." @default.
- W3088368819 created "2020-10-01" @default.
- W3088368819 creator A5001206795 @default.
- W3088368819 creator A5002598380 @default.
- W3088368819 creator A5004138406 @default.
- W3088368819 creator A5018615124 @default.
- W3088368819 creator A5023417084 @default.
- W3088368819 creator A5023916385 @default.
- W3088368819 creator A5027538973 @default.
- W3088368819 creator A5031192012 @default.
- W3088368819 creator A5034721195 @default.
- W3088368819 creator A5036901015 @default.
- W3088368819 creator A5048881215 @default.
- W3088368819 creator A5058841016 @default.
- W3088368819 creator A5067170645 @default.
- W3088368819 creator A5071242826 @default.
- W3088368819 creator A5071382373 @default.
- W3088368819 creator A5071675004 @default.
- W3088368819 creator A5074066589 @default.
- W3088368819 creator A5076200732 @default.
- W3088368819 creator A5087842420 @default.
- W3088368819 creator A5088501406 @default.
- W3088368819 date "2020-09-01" @default.
- W3088368819 modified "2023-09-28" @default.
- W3088368819 title "1712P Risk of SARS-CoV-2 infection and outcome after infection: Experience from the day-care unit at CHU Liège in Belgium" @default.
- W3088368819 doi "https://doi.org/10.1016/j.annonc.2020.08.1776" @default.
- W3088368819 hasPublicationYear "2020" @default.
- W3088368819 type Work @default.
- W3088368819 sameAs 3088368819 @default.
- W3088368819 citedByCount "1" @default.
- W3088368819 countsByYear W30883688192021 @default.
- W3088368819 crossrefType "journal-article" @default.
- W3088368819 hasAuthorship W3088368819A5001206795 @default.
- W3088368819 hasAuthorship W3088368819A5002598380 @default.
- W3088368819 hasAuthorship W3088368819A5004138406 @default.
- W3088368819 hasAuthorship W3088368819A5018615124 @default.
- W3088368819 hasAuthorship W3088368819A5023417084 @default.
- W3088368819 hasAuthorship W3088368819A5023916385 @default.
- W3088368819 hasAuthorship W3088368819A5027538973 @default.
- W3088368819 hasAuthorship W3088368819A5031192012 @default.
- W3088368819 hasAuthorship W3088368819A5034721195 @default.
- W3088368819 hasAuthorship W3088368819A5036901015 @default.
- W3088368819 hasAuthorship W3088368819A5048881215 @default.
- W3088368819 hasAuthorship W3088368819A5058841016 @default.
- W3088368819 hasAuthorship W3088368819A5067170645 @default.
- W3088368819 hasAuthorship W3088368819A5071242826 @default.
- W3088368819 hasAuthorship W3088368819A5071382373 @default.
- W3088368819 hasAuthorship W3088368819A5071675004 @default.
- W3088368819 hasAuthorship W3088368819A5074066589 @default.
- W3088368819 hasAuthorship W3088368819A5076200732 @default.
- W3088368819 hasAuthorship W3088368819A5087842420 @default.
- W3088368819 hasAuthorship W3088368819A5088501406 @default.
- W3088368819 hasBestOaLocation W30883688191 @default.
- W3088368819 hasConcept C116675565 @default.
- W3088368819 hasConcept C126322002 @default.
- W3088368819 hasConcept C141071460 @default.
- W3088368819 hasConcept C159047783 @default.
- W3088368819 hasConcept C162324750 @default.
- W3088368819 hasConcept C187212893 @default.
- W3088368819 hasConcept C2778173179 @default.
- W3088368819 hasConcept C2779134260 @default.
- W3088368819 hasConcept C50522688 @default.
- W3088368819 hasConcept C71924100 @default.
- W3088368819 hasConceptScore W3088368819C116675565 @default.
- W3088368819 hasConceptScore W3088368819C126322002 @default.
- W3088368819 hasConceptScore W3088368819C141071460 @default.
- W3088368819 hasConceptScore W3088368819C159047783 @default.
- W3088368819 hasConceptScore W3088368819C162324750 @default.
- W3088368819 hasConceptScore W3088368819C187212893 @default.
- W3088368819 hasConceptScore W3088368819C2778173179 @default.
- W3088368819 hasConceptScore W3088368819C2779134260 @default.
- W3088368819 hasConceptScore W3088368819C50522688 @default.
- W3088368819 hasConceptScore W3088368819C71924100 @default.
- W3088368819 hasLocation W30883688191 @default.
- W3088368819 hasLocation W30883688192 @default.
- W3088368819 hasOpenAccess W3088368819 @default.
- W3088368819 hasPrimaryLocation W30883688191 @default.
- W3088368819 hasRelatedWork W1586374228 @default.
- W3088368819 hasRelatedWork W2003938723 @default.
- W3088368819 hasRelatedWork W2047967234 @default.
- W3088368819 hasRelatedWork W2089201504 @default.
- W3088368819 hasRelatedWork W2118496982 @default.
- W3088368819 hasRelatedWork W2364998975 @default.
- W3088368819 hasRelatedWork W2369162477 @default.
- W3088368819 hasRelatedWork W2439875401 @default.
- W3088368819 hasRelatedWork W4238867864 @default.
- W3088368819 hasRelatedWork W2525756941 @default.
- W3088368819 hasVolume "31" @default.
- W3088368819 isParatext "false" @default.
- W3088368819 isRetracted "false" @default.
- W3088368819 magId "3088368819" @default.
- W3088368819 workType "article" @default.